Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | WRN | Q14191 | 1/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13080613 | 0.84 | NAAA (0.35) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL12016475 | 0.84 | NAAA (0.35) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL11917866 | 0.81 | NAAA (0.33) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL974718 | 0.76 | HTT (0.50) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL27997782 | 0.74 | ALDH1A1 (0.41) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL2692003 | 0.72 | NAAA (0.39) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL27870698 | 0.72 | NAAA (0.39) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL8402125 | 0.71 | NAAA (0.38) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL12112110 | 0.71 | NAAA (0.38) | NAAAALDH1A1CYP1A2HPGDCYP2C19 | |
| SCHEMBL1326486 | 0.71 | NAAA (0.44) | NAAAALDH1A1CYP1A2HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8241831-B2 | Acid generating agent for chemically amplified resist compositions | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2012-08-14 | — | — | US | disclosed |
| US-20090291390-A1 | Acid generating agent for chemically amplified resist compositions | KOREA KUMHO PETROCHEMICAL CO., LTD. (KR) | 2009-11-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090291390-A1 | Acid generating agent for chemically amplified resist compositions | ABCC1, CBR1, ARSA | NAAA 22/4885ALDH1A1 102/4885CYP1A2 852/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.